Zhang Qi, Han Zhenzhen, Zhu Yanbo, Chen Jingcheng, Li Wei
Stem Cell and Cancer Center, The First Hospital of Jilin University, Changchun, China.
Int J Stem Cells. 2020 Nov 30;13(3):312-325. doi: 10.15283/ijsc20097.
Recently, evidences show that cancer stem cells (CSCs) are a type of cancer cell group with self-renewal and play a huge role in tumor recurrence, metastasis, and drug resistance. Finding new treatment directions and targets for cancer prognosis and reducing mortality has become a top priority. OCT4, as a transcription factor, participates in maintaining the stem characteristics of CSCs, but the mechanism of OCT4 is often overlooked. In this review, we try to illustrate the mechanism by which OCT4 plays a role in CSCs from the perspective of genetic modification of OCT4, non-coding RNA, complexes and signaling pathways associated with OCT4. Our ultimate goal is to provide new targets for cancer treatment to prolong the survival of cancer patients.
最近,有证据表明癌症干细胞(CSCs)是一类具有自我更新能力的癌细胞群,在肿瘤复发、转移和耐药性方面发挥着巨大作用。寻找癌症预后的新治疗方向和靶点并降低死亡率已成为当务之急。OCT4作为一种转录因子,参与维持癌症干细胞的干性特征,但其机制常被忽视。在本综述中,我们试图从OCT4的基因修饰、与OCT4相关的非编码RNA、复合物和信号通路的角度阐明OCT4在癌症干细胞中发挥作用的机制。我们的最终目标是为癌症治疗提供新靶点,以延长癌症患者的生存期。